Titolo |
Pubblicato in |
Anno |
Oxygen supplementation for pulmonary arterial hypertension. clues from the REVEAL registry |
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION |
2018 |
Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension. clinical and haemodYnamic long-term efficacy (ITALY study) |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2018 |
Initial combination therapy for patients with pulmonary arterial hypertension (PAH). a budget impact analysis from the perspective of the italian national healthcare system |
EXPERT OPINION ON ORPHAN DRUGS |
2018 |
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease. results from PATENT-1 and PATENT-2 |
ANNALS OF THE RHEUMATIC DISEASES |
2017 |
Letter to the editor about the paper “right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension” by murata et al |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2017 |
Efficacy of 1, 5, and 20mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension. a randomized, double-blind study with open-label extension |
BMC PULMONARY MEDICINE |
2017 |
Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2017 |
Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial |
BMC CARDIOVASCULAR DISORDERS |
2017 |
Mortality in pulmonary arterial hypertension. prediction by the 2015 european pulmonary hypertension guidelines risk stratification model |
EUROPEAN RESPIRATORY JOURNAL |
2017 |
RESPITE. switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors |
EUROPEAN RESPIRATORY JOURNAL |
2017 |
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension |
EUROPEAN RESPIRATORY JOURNAL |
2017 |
An official european respiratory society statement. pulmonary haemodynamics during exercise |
EUROPEAN RESPIRATORY JOURNAL |
2017 |
La terapia di combinazione orale nel trattamento dei pazienti con ipertensione arteriosa polmonare. quali evidenze dagli studi a lungo termine [Oral combination therapy for the treatment of patients with pulmonary arterial hypertension. what evidence from long-term studies] |
GIORNALE ITALIANO DI CARDIOLOGIA |
2017 |
Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension |
CHEST |
2016 |
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention. 2016 consensus position of the italian society of cardiology |
JOURNAL OF CARDIOVASCULAR MEDICINE |
2016 |
Pre-capillary, combined, and post-capillary pulmonary hypertension. a pathophysiological continuum |
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
2016 |
Preoperative evaluation of patients undergoing lung resection surgery. defining the role of the anesthesiologist on a multidisciplinary team |
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA |
2016 |
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease. a randomized controlled multicenter clinical trial |
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION |
2016 |
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension |
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION |
2016 |
Badagliacca R, Papa S, Valli G, Pezzuto B, Poscia R, Murace AC, Marinelli L, Manzi G, Berardi D, Sciomer S, Palange P, Fedele F, Vizza CD. “Incremental benefit of cardiopulmonary exercise testing for the prediction of outcome in stable prevalent idiopathic pulmonary arterial Hypertension patients”. Comunicazione Abstract del 77° Congresso Nazionale della Società Italiana di Cardiologia (2016) |
|
2016 |